72066323RFA00007: Lowlands Health Activity
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Ethiopia USAID-Addis Ababa notices from 2023.
Ethiopia USAID-Addis Ababa offered grants of up to $35.0 million (at least $30.0 million) to any type of organization. It expected to make one award worth $35.0 million in total. Applications closed on May 24, 2023.
From the official notice on Grants.gov, last changed April 10, 2023. Checked November 7, 2026.
- Award ceiling$35.0 million
- Award floor$30.0 million
- Total funding$35.0 million
- Expected awards1
- Cost sharingRequired
- Funding typeCooperative Agreement
Key dates
| Posted | April 10, 2023 |
|---|---|
| Deadline | May 24, 2023 |
| Archived by Grants.gov | June 23, 2023 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $35.0 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
The purpose of this Activity is to improve health and nutrition outcomes by increasing access, quality, and utilization of RMNCAH-N services in pastoral geographies of Ethiopia. To achieve the IRs outlined in Section 5, the Recipient must design evidence-based, contextualized, gender- and youth-sensitive, and pragmatic approaches and interventions for pastoral areas. All applications should propose the ideal mix of interventions to improve access, quality, and utilization of RMNCAH-N services. Applicants must develop a comprehensive plan that includes cost-effective, sustainable (i.e., beyond development partner funding) interventions and put together a plan that measures the cost of each proposed intervention at district or health facility level. The Recipient must plan to engage in cost-effective analysis on proposed interventions throughout the Activity to inform its retooling of interventions towards maximum results. The Activity will also have a $1 million crisis modifier set aside and will be flexible to identify, assess, and support emergency response efforts to man-made or natural disasters, including disease outbreaks, drought, conflict, etc., that can save lives, restore/sustain health service delivery, and protect critical interventions for community health, while maintaining public health development gains. USAID’s New Partnerships Initiative (NPI) aims to diversify USAID’s partner base by creating avenues for new and underutilized partners to work with USAID. Through NPI, the Agency promotes local leadership, seeks bold and innovative approaches to fostering self-reliance, and identifies new sources of funding to sustain partnership and scale impact. As such, focus on local capacity development (structured and with milestones documenting progress), knowledge, ownership (through co-financing agreements), and sustainability (cost-effective and beyond development partner funding) is encouraged for all applications. Most importantly, USAID/Ethiopia embraces and would like to foster ‘out-of-the-box’ thinking to meet the new, ever-evolving demands and challenges that the Activity’s pastoral areas are facing in health programming.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 72066323RFA00007 still open?
No. It closed on May 24, 2023.
Who can apply for Lowlands Health Activity?
Ethiopia USAID-Addis Ababa accepted applications from any type of organization.
What is the deadline for Lowlands Health Activity?
Closed May 24, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $35.0 million each. About $35.0 million in total for one award.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)